Key Takeaways for Practice Owners
- Most dentists rely on rule-of-thumb valuations that often collapse under buyer scrutiny, which can trigger last-minute price cuts.
- A diligence-grade, CPA-led EBITDA valuation provides a defensible number and a 3-to-7-year runway to improve it before going to market.
- Income-based methods that use EBITDA or SDE can translate into realistic retirement-income projections, while collections or asset methods often distort true value.
- Choosing between a doctor-to-doctor sale and a DSO transaction can change after-tax proceeds by 15–30%, so side-by-side financial modeling can be useful.
- McLerran helps dentists convert a verified valuation into a retirement-income plan. Start with a free, confidential discovery call.
What a Diligence-Grade EBITDA Valuation Really Shows You
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. In plain terms, it measures how much cash a business generates from core operations before financing costs and non-cash charges. For a dental practice, a reliable EBITDA figure comes from a process called normalization, which strips out personal, discretionary, or one-time expenses so earnings reflect what a new owner would likely experience.
Those stripped-out items are called add-backs. Common add-backs in a dental practice include the owner’s above-market compensation, personal vehicle expenses run through the business, one-time equipment purchases, and family members on payroll who will not remain after a sale. SDE, or Seller’s Discretionary Earnings, is a related metric that adds the owner’s full compensation back into earnings and is used primarily in doctor-to-doctor transactions where the buyer is also an owner-operator.
Understanding these add-backs is essential because a diligence-grade valuation goes further than a spreadsheet estimate. It cross-references practice management software data against tax returns and bank deposits, documents every add-back with supporting evidence, and produces a number that any accountant, including the buyer’s, would likely view as defensible. Practices with clean, provable collections tied to bank deposits often command higher prices than similar practices with unverified numbers, which can directly affect retirement proceeds.
McLerran & Associates builds every engagement on a CPA-led EBITDA analysis completed before the practice goes to market. Because the homework is done up front, the valuation is less likely to be re-traded when a buyer examines the details, which is where many unrepresented sellers lose money.
Learn how a diligence-grade valuation compares to your current estimate in a free discovery call with McLerran & Associates.
How the Three Valuation Methods Affect Retirement Cash Flow
Three main methodologies are used to value dental practices, and each can produce a very different number for the same office. Knowing which method applies to your situation, and why, can be a key step in building a realistic retirement-income projection.
| Method | How It Works | When It Applies | Retirement Cash-Flow Implication |
|---|---|---|---|
| Income (EBITDA / SDE) | Normalizes earnings and applies a market multiple. General practices in private sales can trade at a median of about 3.8× SDE. DSO buyers apply EBITDA multiples that scale with practice size and profitability. | All transactions; required for DSO and multi-location deals. | Often the most accurate predictor of net proceeds and the only method that typically survives buyer diligence. |
| Market (Collections %) | Values general dental practices in private sales at 65% to 85% of annual gross collections, with the range shaped by overhead, owner dependence, technology, and location. | Solo GP practices under about $1.5M in revenue; useful as a secondary check. | Can understate value for high-margin or multi-doctor practices. The collections method is effectively obsolete in most DSO or private equity transactions. |
| Asset | Values tangible assets such as equipment, technology, and leasehold improvements at fair market value. | Sets a valuation floor and rarely drives the headline number, since 70 to 85% of dental practice value can be intangible goodwill. | Most relevant when goodwill is minimal or the practice is being wound down, so it is not usually a stand-alone retirement-planning tool. |
For a practice collecting $1M annually, a 70% collections multiple produces a $700,000 valuation. A 5× EBITDA multiple on $170,000 in adjusted EBITDA produces $850,000, which is a $150,000 gap from the same practice based only on the method used. For a $2M revenue practice, the collections method may yield $1.3M to $1.7M for a private buyer, while a DSO buyer applying 6× to 7× EBITDA may reach $2.4M to $2.8M, which can be a 40 to 80% premium for the same office.
The income method connects most directly to a retirement-income model because it starts with verified cash flow rather than gross revenue.
Find out which valuation method fits your practice and how that choice can affect your retirement timeline.
Comparing Doctor-to-Doctor and DSO Sales for Net Proceeds
The path to market, whether selling to another dentist or affiliating with a DSO or private equity partner, can create very different after-tax outcomes for the same practice. The headline multiple tells only part of the story because deal structure, tax treatment, and equity rollover all shape what ultimately reaches a retirement account.
| Dimension | Doctor-to-Doctor | DSO / Private Equity |
|---|---|---|
| Typical valuation basis | 65% to 75% of annual collections, or about 3.5× to 4.5× EBITDA | 5× to 8× EBITDA for a single location, and 8× to 12× for larger multi-location platforms |
| Cash at close | Often 80% to 100% cash at closing with no rollover equity requirement | Often 60% to 80% cash at close, with 10% to 30% in equity rollover and a multi-year clinical commitment |
| Post-tax net-to-seller range | Often 20% to 35% of headline price after federal capital gains, state income tax, depreciation recapture, and ordinary income on non-capital assets | DSO sale tax treatment can sometimes reduce total tax liability by about 15% to 25% versus an independent exit because of installment treatment, equity rollovers, and earnout timing |
| Clinical commitment after sale | Often a 4 to 8 week work-back, then full exit | DSO buyers generally require a 2 to 5 year clinical commitment before full retirement proceeds are realized |
A DSO usually pays a higher headline multiple, yet the after-tax, after-risk net-to-seller is sometimes, though not always, higher than a private-buyer transaction. The equity rollover component introduces a second variable. Up to about 40% of a DSO deal can be paid in equity rather than cash, which means the owner is effectively investing in the DSO and can benefit from evaluating it as an investment.
The difference between a well-structured sale and a poorly structured one can reach 15 to 30% of net-to-seller. That gap often comes from decisions on asset versus stock sale treatment, purchase price allocation, and pre-sale planning. McLerran & Associates prepares multi-year, multi-structure financial forecasts across both paths so owners compare realistic after-tax cash, not just headline numbers.
3–7-Year Pre-Retirement Checklist to Lift Practice Value
The years just before a sale can be some of the most influential for retirement income. Each item below connects to a measurable valuation outcome.
- Reduce owner production dependence. Practices where the owner produces more than 60% of total doctor production can trade at 2.5× to 3.2× SDE because buyers worry about patient attrition after transition. Ramping an associate so the owner produces less than 50% of total clinical revenue can add one or more turns to the EBITDA multiple. Adding one producing associate can increase a practice’s valuation by about one full turn of EBITDA because collections become more transferable after the owner exits.
- Improve payer mix. Reducing PPO concentration from 80% to 55% over 30 months can add $50,000 to $100,000 to the sale price of a $900,000 collections practice. A Medicaid mix above 30% can compress multiples by 15% to 25%, while a fee-for-service-dominant payer mix often supports premium valuations.
- Strengthen hygiene revenue. Hygiene production above 30% of total collections with an above-80% recall rate signals stable recurring revenue and serves as a key due-diligence metric for many DSO buyers.
- Secure favorable lease terms. Short remaining lease terms under 5 years, unfavorable renewal clauses, or rent above $35 per square foot can compress practice value by $100,000 to $300,000. Negotiating at least a 10-year lease with renewal options before going to market can remove a common buyer objection.
- Clean up the financials. Document every add-back with supporting evidence, since this documentation helps you defend EBITDA under buyer scrutiny. After add-backs are clear, owners planning exit within 3 to 5 years who target at least 24% EBITDA and diversify payer mix toward at least 40% fee-for-service can often add $200,000 to $500,000 to exit value on a $450,000 SDE practice.
- Address real estate early. Decide whether to sell or retain the building before the practice goes to market. Real estate decisions can affect deal structure, tax treatment, and buyer financing, and they are usually easier to resolve with several years of lead time.
Build a practice-specific optimization plan with McLerran & Associates that aligns with your retirement goals.
Common Obstacles That Reduce Value and How to Respond
Even well-run practices face issues that can suppress value or disrupt a transaction. Identifying these issues early, while there is still time to act, can be one of the main benefits of a professional valuation completed years before retirement.
- Weak or unverifiable financials. Industry estimates suggest embezzlement exposure in 60 to 70% of dental practices. Discovery during buyer diligence can sharply discount offers or end deals. A practical response is a forensic review of collections, deposits, and payroll before the practice goes to market, rather than after a buyer raises concerns.
- Owner-dependence risk. Owner-dependent practices where the selling doctor produces 90% or more of clinical revenue often receive 10% to 20% valuation haircuts regardless of the multiple method. Associate development can reduce this risk, and that process takes time, which supports planning on a 3-to-7-year horizon.
- Tax surprises at closing. In a dental practice sale, 60% to 90% of the value is often classified as goodwill, including personal and enterprise components, and taxed at long-term capital gains rates. Equipment and supply inventory are taxed as ordinary income, and depreciation recapture can add more tax. Pre-sale entity restructuring and purchase price allocation planning with a qualified CPA, completed well before the transaction, can help preserve a meaningful share of proceeds.
- Timing misalignment. Financial modeling can show that the net present value of future earnings may fall below the after-tax sale price of the practice at certain ages. In those cases, waiting too long can reduce lifetime economic outcome. At the same time, dentists who sell before about age 58 often realize lower long-term net income than those who continue working past 58. A financial model that maps both paths, continuing to practice versus selling, can help identify the most favorable window for a specific owner.
- Buyer-fit concerns. The highest bidder is not always the right buyer. Protecting staff, patients, and legacy can require vetting buyers on culture and operational track record, not just offer price. McLerran & Associates has blacklisted DSOs known for poor post-close environments so those buyers do not reach the table.
Identify which obstacles apply to your practice and how much time you may have to address them.
Conclusion: Use Valuation as a Retirement Planning Tool
A dental practice valuation can serve as a retirement-planning tool rather than just a transaction document. When built on a diligence-grade EBITDA analysis, the valuation number can become the foundation for decisions about path to market, expected after-tax cash, remaining years in practice, and whether proceeds can support the retirement lifestyle you have in mind.
Many dentists reach this decision point with a number that has never been tested under buyer-level scrutiny. When a buyer’s diligence team exposes a gap, the owner can lose negotiating leverage, time, and a meaningful share of proceeds. The 3-to-7-year window before retirement is often the period when a professional valuation can still improve the outcome, not simply describe the current state.
McLerran & Associates has evaluated more than 10,000 dental practices, closed about 2,000 transactions representing roughly $2 billion in volume, and transacts at an 85 to 90% rate compared to an industry norm closer to 35 to 40%. The firm works both the doctor-to-doctor and DSO paths in roughly equal measure, so each client receives a genuine side-by-side comparison rather than a recommendation shaped by a single preferred path. Every engagement is built on a CPA-led EBITDA valuation designed to hold up under buyer scrutiny, and each process aims to create competition so the owner, not the buyer, helps set the terms.
To see what your practice is worth today, what it could be worth with targeted improvements, and how those numbers can translate into after-tax retirement income, contact McLerran & Associates. Call (512) 900-7989, email info@dentaltransitions.com, or schedule a free, confidential discovery call with McLerran & Associates.
Frequently Asked Questions
How do I convert my practice’s sale price into a monthly retirement income number?
The starting point is your after-tax net proceeds, not the headline sale price. From the gross valuation, subtract estimated taxes such as federal capital gains, state income tax, depreciation recapture, and any ordinary income on non-capital assets, along with broker fees and remaining practice debt. The result is the investable capital available to generate retirement income. Many planners use a sustainable annual withdrawal rate, often discussed in the 3% to 4% range of invested assets per year, to estimate monthly income. For example, $2 million in net investable proceeds at a 4% withdrawal rate would generate about $80,000 per year, or roughly $6,700 per month, before personal income taxes on distributions. That figure then needs to be compared with your actual monthly lifestyle expenses to see whether the proceeds appear sufficient or whether additional savings, a later sale date, or practice improvements may be needed. McLerran & Associates prepares multi-year, multi-structure financial forecasts across both doctor-to-doctor and DSO paths so owners can review a realistic retirement-income number before committing to any transaction.
What is the difference between SDE and EBITDA, and which one matters for my sale?
SDE, or Seller’s Discretionary Earnings, adds the owner’s full compensation back into the practice’s earnings on the assumption that the buyer is also an owner-operator who will replace that income. It is the standard metric for many doctor-to-doctor transactions involving smaller, solo practices. EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, replaces the owner’s compensation with a market-rate associate salary and isolates the practice’s operating profit independent of who owns it. DSO and private equity buyers use EBITDA because they are acquiring a business, not a job. For a practice where the owner earns well above a market associate salary, the EBITDA figure will usually be lower than the SDE figure, but the EBITDA multiple applied by institutional buyers is often higher, which can still produce a larger gross valuation. The metric that matters most depends on which buyer pool you plan to target, so a side-by-side valuation covering both paths can help support an informed decision.
How much of a DSO deal is typically paid in cash versus equity, and what does that mean for retirement planning?
DSO transactions are almost always structured as a mix of cash at close, equity rollover, and sometimes an earnout tied to future performance. Cash at close often represents 60% to 80% of the total deal value, with about 10% to 30% paid in equity held at either the joint-venture level or the holding-company level. The equity portion is not liquid at closing and functions as an investment in the DSO that may pay out at a future liquidity event, typically when the DSO is recapitalized or sold. For retirement planning, this structure means a significant portion of the headline valuation may not be available for 3 to 7 years after the initial transaction. The equity can ultimately be worth more than its face value if the DSO performs well, or less if the DSO struggles. McLerran & Associates helps owners evaluate the DSO as an investment by examining profitability, growth, management quality, and financial backing before owners accept equity as part of a deal.
What are the most impactful things I can do in the next 3 years to increase my practice’s sale price?
The highest-return actions appear in the 3–7-Year Pre-Retirement Checklist above. The four most influential areas usually include reducing owner-production dependence, improving payer mix toward more fee-for-service revenue, strengthening hygiene revenue and recall rates, and securing a long-term lease with favorable renewal options. Each of these changes can take time to appear in trailing financials, which is why a valuation performed 3 to 7 years before retirement, rather than a few months before, can give you time to act on the findings and potentially move the number.
Why does McLerran & Associates charge for a valuation when other firms offer free ones?
A free valuation often serves as a lead-generation tool, providing a quick estimate designed to attract sellers rather than withstand buyer scrutiny. When a buyer’s diligence team reviews the actual financials, a weak valuation can be re-traded downward and the seller can lose negotiating leverage at a difficult moment. McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis from the ground up by cross-referencing practice management software data against tax returns and bank deposits and documenting every add-back with supporting evidence. The goal is a number that can hold up when buyers review the details, which can support a transaction that closes near the agreed price instead of being renegotiated. The firm’s approximately 85 to 90% transaction rate, compared to an industry norm closer to 35 to 40%, reflects the difference between a valuation built to sell a practice and one built mainly to generate a phone call.
